I. Elman

发表

Theorizing the Role of Dopaminergic Polymorphic Risk Alleles with Intermittent Explosive Disorder (IED), Violent/Aggressive Behavior and Addiction: Justification of Genetic Addiction Risk Severity (GARS) Testing

K. Blum, P. Thanos, R. Badgaiyan, 2022, Journal of personalized medicine.

Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids

K. Blum, D. Barh, P. Thanos, 2022, Journal of personalized medicine.

Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?

K. Blum, D. Barh, P. Thanos, 2022, Journal of personalized medicine.

Why haven't we solved the addiction crisis?

K. Blum, D. Barh, P. Thanos, 2022, Journal of the Neurological Sciences.

Genetic Addiction Risk and Psychological Profiling Analyses for “Preaddiction” Severity Index

K. Blum, D. Barh, P. Thanos, 2022, Journal of personalized medicine.

Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia’s Effect on Addictive and Non-Addictive Behaviors in a Nuclear Family

K. Blum, P. Thanos, R. Badgaiyan, 2022, Journal of personalized medicine.

Hypothesizing That Pediatric Autoimmune Neuropsychiatric Associated Streptococcal (PANDAS) Causes Rapid Onset of Reward Deficiency Syndrome (RDS) Behaviors and May Require Induction of “Dopamine Homeostasis”

K. Blum, P. Thanos, D. Baron, 2022, Open journal of immunology.

Statistical Validation of Risk Alleles in Genetic Addiction Risk Severity (GARS) Test: Early Identification of Risk for Alcohol Use Disorder (AUD) in 74,566 Case–Control Subjects

K. Blum, P. Thanos, R. Badgaiyan, 2022, Journal of personalized medicine.

Understanding that Addiction Is a Brain Disorder Offers Help and Hope

K. Blum, P. Thanos, R. Badgaiyan, 2022, Health.

Positive Clinical Outcomes for Severe Reported Pain Using Robust Non-Addictive Home Electrotherapy—A Case-Series

K. Blum, D. Barh, P. Thanos, 2023, Journal of Personalized Medicine.

“Preaddiction” construct and reward deficiency syndrome: genetic link via dopaminergic dysregulation

K. Blum, P. Thanos, R. Badgaiyan, 2022, Annals of translational medicine.

How to Combat the Global Opioid Crisis

K. Blum, D. Baron, A. Bowirrat, 2023, CPQ neurology and psychology.

Understanding the Scientific Basis of Post-traumatic Stress Disorder (PTSD): Precision Behavioral Management Overrides Stigmatization

K. Blum, P. Thanos, M. Oscar-Berman, 2019, Molecular Neurobiology.

Insurance Companies Fighting the Peer Review Empire without any Validity: the Case for Addiction and Pain Modalities in the face of an American Drug Epidemic.

K. Blum, P. Thanos, R. Badgaiyan, 2018, SEJ surgery and pain.

Personalized repetitive transcranial magnetic stimulation (prtms®) for post-traumatic stress disorder (ptsd) in military combat veterans

K. Blum, J. Cadet, J. Yesavage, 2023, Heliyon.

Evidence for the DRD2 Gene as a Determinant of Reward Deficiency Syndrome (RDS)

K. Blum, P. Thanos, M. Makale, 2023, Clinical and experimental psychology.

Preliminary Observations of Personalized Repetitive Magnetic Stimulation (PrTMS) Guided by EEG Spectra for Concussion

P. Thanos, D. Baron, Catherine A. Dennen, 2023, Brain sciences.

Metheamphetamine for Children: Are We Over or Under Dosing?

K. Blum, P. Thanos, R. Badgaiyan, 2023, Journal of addiction psychiatry.

Invited Expert Opinion- Bioinformatic and Limitation Directives to Help Adopt Genetic Addiction Risk Screening and Identify Preaddictive Reward Dysregulation: Required Analytic Evidence to Induce Dopamine Homeostatsis

P. Thanos, R. Badgaiyan, D. Baron, 2023, Medical research archives.